Korean J Blood Transfus.
2022 Dec;33(3):178-181. 10.17945/kjbt.2022.33.3.1 7 8.
Transfusion of RhD-Positive Blood Components to Serologic RhD-Negative Patients-Review of Current Literature: An Opinion
- Affiliations
-
- 1Department of Laboratory Medicine and Genetics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
- KMID: 2537224
- DOI: http://doi.org/10.17945/kjbt.2022.33.3.1 7 8
Abstract
- Among RhD variants, it is considered safe to transfuse RhD positive blood to “Asia-type” DEL and weak D type 1, 2, and 3 recipients. However, transfusing RhD-positive blood cells in the “Asia-type” DEL, (serologically typed as RhD-negative), is still a cause for concern among clinicians. Here, the safety of transfusing RhD-positive blood components to “Asia-type” DEL recipients is re-emphasized by reviewing previously published literature.
Keyword
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Transfusion in RhD Mismatch Hematopoietic Stem Cell Transplantation
- The Experience of RHD Genotyping in D-negative Blood Donors
- Transfusion of RhD-Positive Blood Products to Asia Type DEL Patients: A Report of Two Cases
- Detection of RHD 1227G>A and 1222T>C Using PCR-Restriction Fragment Length Polymorphism
- Clinical Indications for RHD Genotyping in Koreans
